Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | E39K |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | PIK3CA E39K lies within the PI3K-ABD domain of the Pik3ca protein (UniProt.org). E39K results in increased cell proliferation and transformation ability in culture (PMID: 29533785, PMID: 29636477), and therefore, is predicted to lead to a gain of Pik3ca protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PIK3CA mutant PIK3CA act mut PIK3CA E39K |
Transcript | NM_006218.4 |
gDNA | chr3:g.179198940G>A |
cDNA | c.115G>A |
Protein | p.E39K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006713658 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
XM_011512894.2 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
NM_006218.3 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
XM_011512894 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
NM_006218 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179198940G>A | c.115G>A | p.E39K | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA E39K | breast cancer | resistant | Buparlisib | Preclinical - Cell culture | Actionable | In a preclinical study, breast cancer cells expressing PIK3CA E39K demonstrated resistance to treatment with Buparlisib (BKM120) in culture (PMID: 29636477). | 29636477 |